Nanomedicinal products: a survey on specific toxicity and side effects

Walter Brand*, Cornelle W. Noorlander, Christina Giannakou, Wim H. De Jong, Myrna W. Kooi, Margriet V. D. Z. Park, Rob J. Vandebriel, Irene E. M. Bosselaers, Joep H. G. Scholl, Robert E. Geertsma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)6107-6129
Number of pages23
JournalInternational Journal of Nanomedicine
Volume12
DOIs
Publication statusPublished - 2017

Keywords

  • adverse effects
  • drug safety
  • immunotoxicity
  • nanomedicine
  • nanotoxicology
  • pharmacovigilance
  • IRON-OXIDE NANOPARTICLES
  • ALBUMIN-BOUND PACLITAXEL
  • LIPOSOMAL DAUNORUBICIN
  • COMPLEMENT ACTIVATION
  • BREAST-CANCER
  • DOXORUBICIN
  • LEUKEMIA
  • IMPACT
  • SAFETY
  • TRIAL

Cite this